These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 20218327)
21. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease. Lyu K; He YL; Li HY; Chen R J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050 [TBL] [Abstract][Full Text] [Related]
22. [Detection of enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Shanghai, 2002]. Yang ZH; Zhu QR; Li XZ; Wang XH; Wang JS; Hu JY; Tang W; Cui AL Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):648-52. PubMed ID: 16191294 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice. Caine EA; Fuchs J; Das SC; Partidos CD; Osorio JE Viruses; 2015 Nov; 7(11):5919-32. PubMed ID: 26593938 [TBL] [Abstract][Full Text] [Related]
24. Analysis and solution of false-positives when testing CVA16 sera using an antibody assay against the EV71 virus. Wang C; You A; Tian X; Zhao M; Chen Y; Lin T; Zheng J; Xiao M; Zhang Y; Kuang L; Zhou Z; Zhu B Virus Res; 2013 Sep; 176(1-2):33-6. PubMed ID: 23707400 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice. Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672 [TBL] [Abstract][Full Text] [Related]
26. [Severe cases with hand, foot and mouth disease: data based on national pilot hand, foot and mouth disease surveillance system]. Zheng YM; Chang ZR; Jiang LL; Ji H; Chen GP; Luo P; Pan JJ; Tian XL; Wei LL; Huo D; Miao ZP; Zou XN; Chen JH; Liao QH Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jun; 38(6):759-762. PubMed ID: 28647978 [No Abstract] [Full Text] [Related]
27. A new animal model containing human SCARB2 and lacking stat-1 is highly susceptible to EV71. Liou AT; Wu SY; Liao CC; Chang YS; Chang CS; Shih C Sci Rep; 2016 Aug; 6():31151. PubMed ID: 27499235 [TBL] [Abstract][Full Text] [Related]
28. Scavenger receptor b2 as a receptor for hand, foot, and mouth disease and severe neurological diseases. Yamayoshi S; Fujii K; Koike S Front Microbiol; 2012; 3():32. PubMed ID: 22363322 [TBL] [Abstract][Full Text] [Related]
29. Predicting Severe Enterovirus 71-Infected Hand, Foot, and Mouth Disease: Cytokines and Chemokines. Zhang W; Huang Z; Huang M; Zeng J Mediators Inflamm; 2020; 2020():9273241. PubMed ID: 32089650 [TBL] [Abstract][Full Text] [Related]
30. Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. Chen P; Song Z; Qi Y; Feng X; Xu N; Sun Y; Wu X; Yao X; Mao Q; Li X; Dong W; Wan X; Huang N; Shen X; Liang Z; Li W J Biol Chem; 2012 Feb; 287(9):6406-20. PubMed ID: 22219187 [TBL] [Abstract][Full Text] [Related]
31. Characterizing Enterovirus 71 and Coxsackievirus A16 virus-like particles production in insect cells. Somasundaram B; Chang C; Fan YY; Lim PY; Cardosa J; Lua L Methods; 2016 Feb; 95():38-45. PubMed ID: 26410190 [TBL] [Abstract][Full Text] [Related]
32. Human SCARB2 Acts as a Cellular Associator for Helping Coxsackieviruses A10 Infection. Yu SL; Chung NH; Lin YC; Liao YA; Chen YC; Chow YH Viruses; 2023 Apr; 15(4):. PubMed ID: 37112912 [TBL] [Abstract][Full Text] [Related]
33. Prokaryotic expression and identification of scavenger receptor B2. Xu T; Lin Z; Wang CH; Li Y; Zhao M; Hua L; Zhu B Acta Virol; 2018; 62(1):50-57. PubMed ID: 29521103 [TBL] [Abstract][Full Text] [Related]
35. Cell and tissue tropism of enterovirus 71 and other enteroviruses infections. Lin JY; Shih SR J Biomed Sci; 2014 Mar; 21(1):18. PubMed ID: 24602216 [TBL] [Abstract][Full Text] [Related]
36. A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge. Lin YL; Chow YH; Huang LM; Hsieh SM; Cheng PY; Hu KC; Chiang BL Sci Rep; 2018 Jul; 8(1):10713. PubMed ID: 30013088 [TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in enterovirus 71 receptors associated with susceptibility and clinical severity. Yen TY; Shih WL; Huang YC; Lee JT; Huang LM; Chang LY PLoS One; 2018; 13(11):e0206769. PubMed ID: 30395634 [TBL] [Abstract][Full Text] [Related]
38. [Expression of EV71-VP1, PSGL-1 and SCARB2 in Tissues of Infants with Brain Stem Encephalitis]. Li M; Kong XP; Liu H; Cheng LX; Huang JL; Quan L; Wu FY; Hao B; Liu C; Luo B Fa Yi Xue Za Zhi; 2015 Apr; 31(2):97-101, 104. PubMed ID: 26245084 [TBL] [Abstract][Full Text] [Related]
39. Estimation of the basic reproduction number of enterovirus 71 and coxsackievirus A16 in hand, foot, and mouth disease outbreaks. Ma E; Fung C; Yip SH; Wong C; Chuang SK; Tsang T Pediatr Infect Dis J; 2011 Aug; 30(8):675-9. PubMed ID: 21326133 [TBL] [Abstract][Full Text] [Related]
40. [Identification of P-selectin glycoprotein ligand-1 as one of the cellular receptors for enterovirus 71]. Nishimura Y; Shimizu H Uirusu; 2009 Dec; 59(2):195-203. PubMed ID: 20218328 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]